表紙
市場調查報告書

細胞培養市場 - 市場佔有率,規模,趨勢,產業分析:2020年∼2026年

Cell Culture Market Share, Size, Trends & Industry Analysis Report By Consumables ; By Product ; By Application and By Regions: Segment Forecast, 2020 - 2026

出版商 Polaris Market Research 商品編碼 953055
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
細胞培養市場 - 市場佔有率,規模,趨勢,產業分析:2020年∼2026年 Cell Culture Market Share, Size, Trends & Industry Analysis Report By Consumables ; By Product ; By Application and By Regions: Segment Forecast, 2020 - 2026
出版日期: 2020年03月01日內容資訊: 英文 110 Pages
簡介

全球細胞培養市場規模,2026年前預計將達到429億美元,在預測期間內預計將以年複合成長率11.8%的速度成長。細胞培養作為評估和治療諸如阿爾茨海默氏病和癌症等疾病的手段,正在迅速發展中。

本報告提供全球細胞培養市場相關調查分析,提供市場概要,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 概要與範圍

第2章 摘要整理

第3章 細胞培養市場考察

  • 細胞培養:產業概述
  • 細胞培養:生態系統分析
  • 細胞培養市場動態
  • 產業分析:波特的五力分析
  • 細胞培養市場PEST分析
  • 細胞培養產業趨勢
  • 競爭排行榜分析

第4章 細胞培養市場規模與預測:各產品類型

  • 主要調查結果
  • 移液管操作
  • 離心機
  • 生物安全性
  • 培養系統
  • 培養箱
  • 冷凍保管

第5章 細胞培養市場規模與預測:各用途類型

  • 主要調查結果
  • 醫藥品開發
  • 組織培養·工程
  • 基因治療
  • 生物醫藥品
  • 毒性實驗
  • 疫苗製造

第6章 細胞培養市場規模與預測:各消耗品類型

  • 主要調查結果
  • 血清
  • 培養基
  • 試劑

第7章 細胞培養市場規模與預測:各地區

  • 主要調查結果
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
  • 南美
    • 巴西
    • 墨西哥
  • 中東·非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯

第8章 企業簡介

  • Becton, Dickinson and Company
  • Biospherix
  • EMD Millipore
  • Eppendorf AG
  • Merck KGaA
  • Sartorius AG
  • Sigma - Aldrich Corporation
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC
  • Promocell GmbH
  • Lonza Group
目錄
Product Code: PM1013

Title:
Cell Culture Market Share, Size, Trends & Industry Analysis Report By Consumables (Media, Sera, Reagents); By Product (Pipetting Instruments, Centrifuges, Biosafety Instruments, Culture Systems, Incubators, Cryostorage Equipment); By Application and By Regions: Segment Forecast, 2020 - 2026.

The global cell culture market is expected to reach USD 42.9 billion by 2026 with a CAGR of 11.8% during the forecast period as per a new study released by Polaris Market Research. The report "Cell Culture Market Share, Size, Trends & Industry Analysis Report By Consumables (Media, Sera, Reagents); By Product (Pipetting Instruments, Centrifuges, Biosafety Instruments, Culture Systems, Incubators, Cryostorage Equipment); By Application and By Regions: Segment Forecast, 2020 - 2026". provides an extensive analysis of present market dynamics and predicted future trends.

Cell culture is swiftly developing as an implement for evaluating and treating ailments such as Alzheimer's and cancer diseases. Major Players are intending on broadening their cell reservoir and enhancing their efficiency by putting significant importance on recruitment of trained experts in order to gain a moderate threshold in the market. It is also estimated that the cell culture technique is also obtaining global acceptance in the food and beverages sector and this trend is anticipated to have a good grip in 2019. Cell culture is also gaining traction as one of the most important aspect in the development of high-quality plant actives.

The requirement for cell culture has improved to an extent where conventional manual handling and development of the culture is incapable fulfill the increasing demands. This has enabled the development of automated considerable scale cell culture outlines that are furnished for providing high output of cell societies of high purity levels and in larger quantities. The constant development of these systems and functions for cell culture has stabilized this market to anticipate a growth and advancement through to 2026. This improvement has moved the market noticeably and the cell culture market is predicted to gain a significant traction during the forecast period.

This growth can be attributed to the developing requirements for biopharmaceutical development, antibodies and protein generation; all of which depend intensely on cytological R&D where cell culture plays a notable part. Growing demand for biopharmaceutical is furthermore assumed to sustain regional market development over the forecast period.

The automated culture systems give remarkably improved limit managing, increased productiveness and reproducible purity levels. Sturdy federal initiatives associating to growing speculations by companies and governments in biopharmaceutical assembling and high undiscovered market openings are some imperative variables representing such quick development.

The United States and Canada represented the biggest market share in 2018, as there are a substantially high variety of R&D going in the area pertaining to cytological examination for proteomics, genomics, and also medication as well as vaccination advancement. Expanding requirement for biopharmaceuticals is likewise prepared for to sustain local market development throughout the forecast period.

The Asia Pacific region is anticipated to witness considerable development during 2019 to 2026 due to the existence of high demand for boosting manufacturing as well as advancement of vaccinations, medications, and also brand-new biologics. Helpful federal government efforts, increasing financial investments by market players and existence of federal governments in biopharma production as well as high untouched possibilities in the market are some of the vital elements which are helping this market to gain traction in this region.

Cell culture sera is estimated to represent over 45% of revenue generated in 2019 due to, high usage in cell culture composition and high prices of the product. It is also expected that the commercialization of sera is likewise anticipated to drive market in coming years.

Some of the major companies are associated with substantial R&D of 3D cell culture as well as complete commercialization of the technically sophisticated cell culture which use greater precision of duplication, better pureness and also quick development. Some of the major companies operating in this market consist of Thermo Fisher Scientific, Sartorius, General Electric, Merck, Sigma-Aldrich Co., LLC, Eppendorf, Promocell, Becton, Dickinson & Company (BD) and Lonza.

Polaris Market Research has segmented the global cell culture market on the basis of product, application, consumables and region:

Cell Culture Product Outlook (Market Revenue in USD Billion, 2015 - 2026)

Pipetting instruments

Centrifuges

Biosafety instruments

Culture systems

Incubators

Cryostorage equipment

Cell Culture Applications Outlook (Market Revenue in USD Billion, 2015 - 2026)

Drug development

Tissue culture & engineering

Gene therapy

Biopharmaceuticals

Toxicity testing

Vaccine production

Cell Culture Consumables Outlook (Market Revenue in USD Billion, 2015 - 2026)

Sera (Fetal bovine serum and others)

Media (Minimum essential, RPMI 1640, DMEM/F-12, F-10, Basel medium eagle, Insect and others)

Reagents (Culture albumin and others)

Cell Culture Regional Outlook (Market Revenue in USD Billion, 2015 - 2026)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Asia Pacific

China

India

Japan

Australia

Latin America

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-aways
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Cell culture Market Insights

  • 3.1. Cell culture - Industry snapshot
  • 3.2. Cell culture - Ecosystem analysis
  • 3.3. Cell culture market dynamics
    • 3.3.1. Cell culture - Market Forces
      • 3.3.1.1. Cell culture Market driver analysis
      • 3.3.1.2. Cell culture Market restraint/challenges analysis
      • 3.3.1.3. Cell culture Market opportunity analysis
  • 3.4. Industry analysis - Porter's five force
  • 3.5. Cell culture market PEST analysis
  • 3.6. Cell culture Industry trends
  • 3.7. Competitive Ranking Analysis

4. Cell culture Market Size and Forecast by Product Type, 2015-2026

  • 4.1. Key findings
  • 4.2. Pipetting instruments
  • 4.3. Centrifuges
  • 4.4. Biosafety instruments
  • 4.5. Culture systems
  • 4.6. Incubators
  • 4.7. Cryostorage equipment

5. Cell culture Market Size and Forecast by Application Type, 2015-2026

  • 5.1. Key findings
  • 5.2. Drug development
  • 5.3. Tissue culture & engineering
  • 5.4. Gene therapy
  • 5.5. Biopharmaceuticals
  • 5.6. Toxicity testing
  • 5.7. Vaccine production

6. Cell culture Market Size and Forecast by Consumables Type, 2015-2026

  • 6.1. Key findings
  • 6.2. Sera (Fetal bovine serum and others)
  • 6.3. Media (Minimum essential, RPMI 1640, DMEM/F-12, F-10, Basel medium eagle, Insect and others)
  • 6.4. Reagents (Culture albumin and others)

7. Cell culture Market Size and Forecast by Regions, 2015-2026

  • 7.1. Key findings
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. UK
    • 7.3.3. France
    • 7.3.4. Italy
  • 7.4. Asia Pacific
    • 7.4.1. China
    • 7.4.2. India
    • 7.4.3. Japan
    • 7.4.4. Australia
  • 7.5. Latin America
    • 7.5.1. Brazil
    • 7.5.2. Mexico
  • 7.6. Middle East & Africa
    • 7.6.1. UAE
    • 7.6.2. Saudi Arabia

8. Company Profiles

  • 8.1. Becton, Dickinson and Company
    • 8.1.1. Overview
    • 8.1.2. Financials
    • 8.1.3. Product Benchmarking
    • 8.1.4. Recent Developments
  • 8.2. Biospherix
    • 8.2.1. Overview
    • 8.2.2. Financials
    • 8.2.3. Product Benchmarking
    • 8.2.4. Recent Developments
  • 8.3. EMD Millipore
    • 8.3.1. Overview
    • 8.3.2. Financials
    • 8.3.3. Product Benchmarking
    • 8.3.4. Recent Developments
  • 8.4. Eppendorf AG
    • 8.4.1. Overview
    • 8.4.2. Financials
    • 8.4.3. Product Benchmarking
    • 8.4.4. Recent Developments
  • 8.5. Merck KGaA
    • 8.5.1. Overview
    • 8.5.2. Financials
    • 8.5.3. Product Benchmarking
    • 8.5.4. Recent Developments
  • 8.6. Sartorius AG
    • 8.6.1. Overview
    • 8.6.2. Financials
    • 8.6.3. Product Benchmarking
    • 8.6.4. Recent Developments
  • 8.7. Sigma - Aldrich Corporation
    • 8.7.1. Overview
    • 8.7.2. Financials
    • 8.7.3. Product Benchmarking
    • 8.7.4. Recent Developments
  • 8.8. Thermo Fisher Scientific, Inc.
    • 8.8.1. Overview
    • 8.8.2. Financials
    • 8.8.3. Product Benchmarking
    • 8.8.4. Recent Developments
  • 8.9. VWR International, LLC
    • 8.9.1. Overview
    • 8.9.2. Financials
    • 8.9.3. Product Benchmarking
    • 8.9.4. Recent Developments
  • 8.10. Promocell GmbH
    • 8.10.1. Overview
    • 8.10.2. Financials
    • 8.10.3. Product Benchmarking
    • 8.10.4. Recent Developments
  • 8.11. Lonza Group
    • 8.11.1. Overview
    • 8.11.2. Financials
    • 8.11.3. Product Benchmarking
    • 8.11.4. Recent Developments